Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT05818462 Recruiting - Cancer Clinical Trials

Bladder and Bone Effects of Pelvic Radiation Therapy in Childhood Cancer Survivors

Start date: July 11, 2023
Phase:
Study type: Observational

The aim of this study is to measure and evaluate the effects of pelvic external beam radiation therapy (EBRT) on lower urinary tract (LUT) function and bone mineralization.

NCT ID: NCT05816460 Not yet recruiting - Cancer Clinical Trials

The Sleepio After Cancer Study

SACS
Start date: May 22, 2023
Phase: N/A
Study type: Interventional

This study will recruit women over the age of 18 with a current or prior cancer diagnosis who have clinical insomnia. This study will examine the efficacy of digital cognitive behavioural therapy for insomnia (dCBT-I) compared to sleep hygiene education.

NCT ID: NCT05810324 Recruiting - Cancer Clinical Trials

18F-FAPI PET/CT in Patients With Various Types of Cancer

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

To evaluate the potential usefulness of 18F-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.

NCT ID: NCT05806983 Not yet recruiting - Cancer Clinical Trials

Evaluation of the Efficiency of the Technology-Based Psychosocial Empowerment Program Program

Start date: September 2023
Phase: N/A
Study type: Interventional

This research was planned to evaluate the effectiveness of the technology-based psychosocial empowerment program for home care for children aged 8-18 years with cancer and their parents as a parallel-group randomized controlled study design.The required institutional permission and ethics committee approval was received.The study group of the study consisted of 72 children and parents (intervention group [n=36], control group [n=36]). Data were collected using the descriptive features form, the General Self-Efficacy Scale-Pediatric Cancer Version, the State and Trait Anxiety Inventory for Children, the Pediatric Cancer Coping Scale, the General Self-Efficacy Scale for parents, the Problem-Solving Scale, and the Cope and Adaptatıon Process Scale. The data were stored in the SPSS 25 program.

NCT ID: NCT05805722 Active, not recruiting - Cancer Clinical Trials

Comprehensive Tobacco Cessation for Cancer Patients and Survivors

Start date: April 12, 2023
Phase: N/A
Study type: Interventional

The purpose of this research study is to learn how best to incorporate tobacco cessation treatment into clinical care for cancer patients, survivors, and caregivers.

NCT ID: NCT05802381 Not yet recruiting - Cancer Clinical Trials

the Safety and Effectiveness of Protein Supplements on Cancer Patients With Nutritional Risk and Malnutrition

Start date: April 2023
Phase: N/A
Study type: Interventional

Nutritional risk and malnutrition is common in cancer patients, which is one of the significant factors affecting the overall survival, toxicity during anticancer treatment, and quality of life among patients with cancer. Previous studies have shown that the increased protein intake can stimulate muscle synthesis, and improve muscle mass, strength, function, overall survival, and quality of life. The current study is going to investigate the effectiveness and safety of protein supplements on patients with cancer, in order to provide a reference for further nutrition treatment.

NCT ID: NCT05802069 Recruiting - Cancer Clinical Trials

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)

Start date: December 19, 2022
Phase:
Study type: Observational

The study is an observational trial for patients undergoing cancer-related interventions and therapy at Medical College of Wisconsin Cancer Center. Projects under this protocol will use patient data that will be collected both retrospectively and prospectively. It will also enable prospective sample collection for specific cancer-related studies.

NCT ID: NCT05801965 Active, not recruiting - Prostate Cancer Clinical Trials

A Digital Therapeutic Solution for Cancer Patients

Start date: April 6, 2023
Phase: N/A
Study type: Interventional

This is a randomized, controlled trial to assess the feasibility of Sidekick Health's digital programs for cancer patients. Participants will be treated with standard of care (SoC) in combination with the digital programs, or SoC only. We will compare the effect of the digital programs in addition to SoC to SoC only, on the cancer-related quality of life (QoL), cancer-related fatigue, and side-effect management.

NCT ID: NCT05800535 Active, not recruiting - Cancer Clinical Trials

JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients

JUMP
Start date: March 1, 2023
Phase:
Study type: Observational

Therapeutic advances in oncology have transformed the prognosis of cancer patients, placing a significant number of them either in a context of recovery or in prolonged remission close to a chronic disease. Thus, the reconquest of a life after cancer becomes possible but raises many challenges for the patient, his entourage, the medical profession and our society. One of the major challenges is the detection and management of treatment side effects for all patients. In addition to the standard organic assessment (glycaemia, creatinine, liver test, blood count), we are mainly interested in muscle deconditioning and cognitive impairment, which are particularly disturbed in these populations. After the evaluation day, patients are referred to the most appropriate structures (Adapted physical activity, sports for health, and rehabilitation at Henry Gabriel Hospital). JUMP research is part of axis 2 of the 2021-2030 cancer plan: "Limiting sequelae and improving quality of life", through sheets 1 (research) / 6 (access and quality) / 7 (prevention). This leads to the concrete implementation on the territory of adapted care channels in the city: medical structure, physiotherapy, Adapted Physical Activity (APA) structures, associative structures; which makes it possible to develop and strengthen the city-hospital link. Finally, it allows the patient to take ownership and get involved in the project, allowing in the future to make them truly active in they care and to advise and motivate their peers. This study is non-interventional, it uses research on data that is already collected as part of conventional care, during the JUMP evaluation day. This study allows the investigators to constitute a cohort of patients to study different parameters related to the disease or to the treatments received. Our main objective in this study is to describe the muscular and neurocognitive impairment of post-cancer patients evaluated as part of the JUMP program.

NCT ID: NCT05799898 Recruiting - Cancer Clinical Trials

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

FAST-TRACK
Start date: March 1, 2022
Phase:
Study type: Observational

Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors. Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors. Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.